Inman Pharmacy owner Mike Reppucci says reimbursements on GLP-1s often come in below the cost to acquire the drugs. (Nicole DeFeudis for Endpoints News)
Local pharmacies say they're struggling to afford GLP-1s
(This story is from our new Health Tech newsletter. If you’d like to sign up, just click here.)
Harry Webb has seen a flurry …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
